ImmuPharma Market Cap

ImmuPharma has a market cap or net worth of 12.24 million as of March 28, 2025. Its market cap has increased by 47.37% in one year.

Market Cap

12.24M

Enterprise Value

11.16M

Revenue

-69.96K

Ranking

n/a

PE Ratio

n/a

Stock Price

3.01

Market Cap Chart

Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 12.24M, a decrease of -66.10%. That is a compound annual growth rate of -5.50%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	12.24M	143.98%
Dec 31, 2024	5.02M	-27.71%
Dec 29, 2023	6.94M	13.16%
Dec 30, 2022	6.13M	-62.85%
Dec 31, 2021	16.51M	-50.56%
Dec 31, 2020	33.40M	24.75%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	177.02B
GSK plc	60.68B
Haleon	35.23B
Smith & Nephew	9.36B
ConvaTec Group	5.28B
Hikma Pharmaceuticals	4.33B
HUTCHMED (China)	2.03B
Genus	1.24B

Market Cap Rankings